Balo’s concentric lesions with concurrent features of Schilder’s disease in relapsing multiple sclerosis: neuropathological findings
Maher Kurdi, David Ramsay
Abstract
Atypical inflammatory demyelinating syndromes are rare neurological diseases that differ from multiple sclerosis (MS), owing to unusual clinicoradiological and pathological findings, and poor responses to treatment. The distinction between them and the criteria for their diagnoses are poorly defined due to the lack of advanced research studies. Balo’s concentric sclerosis (BCS) and Schilder’s disease (SD) are two of these syndromes and can present as monophasic or in association with chronic MS. Both variants are difficult to distinguish when they present in acute stages. We describe an autopsy case of middle-aged female with a chronic history of MS newly relapsed with atypical demyelinating lesions, which showed concurrent features of BCS and SD. We also describe the neuropathological findings, and discuss the overlapping features between these two variants.
Keywords
References
1. Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016;15(9):967-81. PMid:27478954. http://dx.doi.org/10.1016/S1474-4422(16)30043-6.
2. Balo J. Encephalitis periaxialis concentrica. Arch Neur Psych. 1928;19(2):242-64. http://dx.doi.org/10.1001/archneurpsyc.1928.02210080044002.
3. Wang C, Zhang KN, Wu XM, et al. Balo’s disease showing benign clinical course and co-existence with multiple sclerosis-like lesions in Chinese. Mult Scler. 2008;14(3):418-24. PMid:18208888. http://dx.doi.org/10.1177/1352458507084036.
4. Purohit B, Ganewatte E, Schreiner B, Kollias S. Balo’s concentric sclerosis with acute presentation and co-existing multiple sclerosis- typical lesions on MRI. Case Rep Neurol. 2015;7(1):44-50. http://dx.doi.org/10.1159/000380813.
5. Graber JJ, Kister I, Geyer H, Khaund M, Herbert J. Neuromyelitis optica and concentric rings of Bal. in the brainstem. Arch Neurol. 2009;66(2):274-5. PMid:19204169. http://dx.doi.org/10.1001/archneurol.2008.539.
6. Hardy TA, Miller DH. Balo’s concentric sclerosis. Lancet Neurol. 2014;13(7):740-6. http://dx.doi.org/10.1016/S1474-4422(14)70052-3.
7. Kira J. Astrocytopathy in Balo’s disease. Mult Scler. 2011;17(7):771-9. PMid:21459811. http://dx.doi.org/10.1177/1352458511400475.
8. Hu W, Lucchinetti CF. The pathological spectrum of CNS infl ammatory demyelinating diseases. Semin Immunopathol. 2009;31(4):439-53. PMid:19779719. http://dx.doi.org/10.1007/s00281-009-0178-z.
9. Stadelmann C, Ludwin S, Tabira T, et al. Tissue preconditioning may explain concentric lesions in Bal.’s type of multiple sclerosis. Brain. 2005;128(Pt 5):979-87. PMid:15774507. http://dx.doi.org/10.1093/brain/awh457.
10. Masaki K, Suzuki SO, Matsushita T, et al. Extensive loss of connexins in Bal.’s disease: evidence for an auto- antibodyindependent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction. Acta Neuropathol. 2012;123(6):887-900. PMid:22438105. http://dx.doi.org/10.1007/s00401-012-0972-x.
11. Schilder P. Zur Kenntnis der sogenannten diffusen Sklerose. (Über Encephalitis periaxialis diffusa.). Gesamate Neurol Psychiatr. 1912;10(1):1-60. http://dx.doi.org/10.1007/BF02901445.
12. Poser CM, Goutie’res F, Carpentier MA, Aicardi J. Schilder’s myelinoclastic diffuse sclerosis. Pediatrics. 1986;77(1):107-12. PMid:3940347.
13. Poser S, Lüer W, Bruhn H, Frahm J, Brück Y, Felgenhauer K. Acute demyelinating disease. Classifi cation and non-invasive diagnosis. Acta Neurol Scand. 1992;86(6):579-85. PMid:1481644. http://dx.doi.org/10.1111/j.1600-0404.1992.tb05490.x.
14. Leuzzi V, Lyon G, Cilio MR, et al. Childhood demyelinating diseases with a prolonged remitting course and their relation to Schilder’s disease: report of two cases. J Neurol Neurosurg Psychiatry. 1999;66(3):407-8. PMid:10084548. http://dx.doi.org/10.1136/jnnp.66.3.407.
Publication date:
12/12/2016